Your search returned 3 results.

Results
	1.	Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. [electronic resource] by Hembrough, Todd A Swartz, Glenn M Papathanassiu, Adonia Vlasuk, George P Rote, William E Green, Shawn J Pribluda, Victor S Producer: 20030731 In: Cancer research vol. 63 Availability: No items available. Save to lists Add to cart (remove)
	2.	ENMD-2076 is an orally active kinase inhibitor with antiangiogenic and antiproliferative mechanisms of action. [electronic resource] by Fletcher, Graham C Brokx, Richard D Denny, Trisha A Hembrough, Todd A Plum, Stacy M Fogler, William E Sidor, Carolyn F Bray, Mark R Producer: 20110728 In: Molecular cancer therapeutics vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Identification and characterization of a very low density lipoprotein receptor-binding peptide from tissue factor pathway inhibitor that has antitumor and antiangiogenic activity. [electronic resource] by Hembrough, Todd A Ruiz, Jose F Swerdlow, Bonnie M Swartz, Glenn M Hammers, Hans J Zhang, Li Plum, Stacy M Williams, Mark S Strickland, Dudley K Pribluda, Victor S Producer: 20040617 In: Blood vol. 103 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search